Iconic Therapeutics
South San Francisco, US · Delaware corporation · 4 known investors
Find your way into Iconic Therapeutics
Sign up to see every warm intro you have to Iconic Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Iconic Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
KD
Kirk DornbushExecutive
WG

William GreeneExecutiveWilliam Greene holds an M.D. and has held leadership roles spanning biotechnology research, clinical program management, global venture capital investment, and board positions at life sciences firms; he has served as CEO of two biotech startups from discovery through fundraising and exits.
Board
JK
Johan KordelBoard director
BR
Bruce RobertsonBoard director
TF

PH
Peter HirthBoard director
JS
Jon SoderstromBoard director
Investors · 4
Elm Street Ventureslisted by Elm Street VenturesNew Haven · $250K – $1M
How we know: Elm Street Ventures's portfolio page · Not right? Tell us
OUP (Osage University Partners)listed by OUP (Osage University Partners)Bala Cynwyd · $1M – $20M
How we know: OUP (Osage University Partners)'s portfolio page · Not right? Tell us
Xeraya Capitallisted by Xeraya CapitalKuala Lumpur
How we know: Xeraya Capital's portfolio page · Not right? Tell us
MPM BioImpactreportedBoston · $1M – $15M
How we know: a partner's Signal profile · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$79M disclosed across 4 rounds · 2014–2019
▶$13MraisedApr 2019 · 37 investors · BiotechnologyRule 506(b)
▶$13MraisedApr 2019 · 37 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bruce CohenDirector
- Peter HirthDirector
- Bruce RobertsonDirector
- Julia GregoryDirector
- Todd FoleyDirector
- William GreeneExecutive Officer, Director
- Kirk DornbushDirector
- Offering amount
- $16.3M
- Amount sold
- $13M
- Proceeds to insiders
- $500K
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.1MraisedJun 2018 · 36 investors · BiotechnologyRule 506(b)
▶$4.1MraisedJun 2018 · 36 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Julia GregoryDirector
- Kirk DornbushDirector
- Peter HirthDirector
- Bruce RobertsonDirector
- William GreeneExecutive Officer, Director
- Todd FoleyDirector
- Offering amount
- $10.9M
- Amount sold
- $4.1M
- Proceeds to insiders
- $500K
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$48.6MraisedNov 2016 · 11 investors · BiotechnologyRule 506(b)
▶$48.6MraisedNov 2016 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Johan KordelDirector
- Bruce RobertsonDirector
- Todd FoleyDirector
- Kirk DornbushExecutive Officer, Director
- Peter HirthDirector
- William GreeneExecutive Officer, Director
- Offering amount
- $48.6M
- Amount sold
- $48.6M
- Proceeds to insiders
- $500K
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13.3MraisedApr 2014 · 40 investors · BiotechnologyRule 506(b)
▶$13.3MraisedApr 2014 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kirk DornbushExecutive Officer, Director
- Todd FoleyDirector
- Bruce RobertsonDirector
- Johan KordelDirector
- William GreeneExecutive Officer, Director
- Jon SoderstromDirector
- Offering amount
- $24.3M
- Amount sold
- $13.3M
- Proceeds to insiders
- $216K
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Iconic Therapeutics went on to found or lead other companies.
Frequently asked questions
- Who are Iconic Therapeutics's investors?
- Iconic Therapeutics's investors include Elm Street Ventures, OUP (Osage University Partners), Xeraya Capital, MPM BioImpact.
- How much funding has Iconic Therapeutics raised?
- Iconic Therapeutics has disclosed $79M raised across 4 rounds.
- Where is Iconic Therapeutics headquartered?
- Iconic Therapeutics is headquartered in South San Francisco, US.

